Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
Pharmabiz

Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis

Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...

39C3: When Molecules Become Cryptographic Functions

Chemist Anne Lüscher showed at 39C3 how synthetic DNA can be used for data storage and tamper-proof authentication.
News-Medical.Net on MSN

Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR

Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
Nature

Optimized library preparation method for next-generation sequencing

The advent of next-generation sequencing has made possible genome analysis at previously unattainable depth. Roche, Illumina and Life Technologies, among others, have developedwell-established ...
eLife

Translational reading frame determines the pathogenicity of C-terminal frameshift deletions in MeCP2: an alternative therapeutic approach

This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...
TipRanks on MSN

Co-Diagnostics announces 1-for-30 reverse stock split

Co-Diagnostics (CODX) announced that it has filed a Certificate of Amendment to its Certificate of Incorporation to effect a reverse stock split ...